期刊文献+

瘦素激活MAPK和PI3K信号通路上调Bcl-2调控肺癌A549细胞增殖 被引量:2

Leptin mediates proliferation of lung cancer A549 cells by upregulation of Bci-2 through activation of MAPK and PI3K signaling pathway
原文传递
导出
摘要 目的探讨瘦素促进肺腺癌A549细胞增殖的分子机制。方法瘦素处理A549细胞,Westernblotting方法检测细胞内Bcl-2的表达;MAPK及P13K信号通路阻滞剂处理A549细胞,Westernblotting方法检测信号通路下游复合物ERK1/2、P—ERK1/2、Akt、P—Akt等蛋白及细胞内Bcl-2的表达变化。结果瘦素促进细胞内Bcl-2的表达,且具有浓度依赖性。瘦素可促进ERK1/2、Akt的磷酸化;用MAPK及P13K信号通路阻滞剂预处理细胞,可以阻滞ERK1/2、Akt的磷酸化,并能够抑制Bcl-2蛋白的表达。结论瘦素可能通过MAPK和P13K通路,介导抗凋亡蛋白Bcl-2的过度表达而使肺腺癌A549细胞呈持续增殖,从而为开发抗肿瘤药物提供新思路。 Objective To investigate the possible molecular mechanism of leptin in stimulating the proliferation of lung adenocarcinoma A549 cells. Methods A549 cells were treated with different concentrations of leptin, and the expression of Bel-2 was evaluated by Western blotting. The expressions of ERK1/2, p-ERK1/2, Akt, p-Akt,and Bcl 2 were detected by Western blotting after MAPK and PI3K signaling pathway blockers were used. Results Leptin increased the expression of Bcl-2 in a dosedependent manner. Leptin also caused ERK1/2 and Akt phosphorylation. Pretreatment with inhibitors of MAPK and PI3K inhibited these responses, and abolished Bcl-2 expression. Conclusions Leptin may mediate the overxpression of anti-apoptotic gene Bcl-2 by activating MAPK and PI3K pathway to promote the continues proliferation of A549 cells, and may represent a target for anticancer drug development.
出处 《国际呼吸杂志》 2013年第6期429-432,共4页 International Journal of Respiration
基金 江苏省科教兴卫工程重点学科开放课题资助(XK18200908)
关键词 瘦素 肺腺癌 信号通路 BCL-2 Leptin Lung adenocarcinoma Signaling pathway Bcl-2
  • 相关文献

参考文献4

二级参考文献66

  • 1胡斐,效小莉,濮德敏,邹倩,李天.瘦素及其受体在宫颈癌中的表达和意义[J].中国组织化学与细胞化学杂志,2006,15(3):297-301. 被引量:5
  • 2薛秀兰,林菊生,宋宇虎,蔡晓坤,周鹤俊.靶向leptin基因的siRNA对大鼠肝星状细胞生物学特性的影响[J].华中科技大学学报(医学版),2006,35(3):331-335. 被引量:5
  • 3Matarese G,Moschos S,Mantzoros CS.Leptin in immunology[J].J Immunol,2005,174(6):3137-3142.
  • 4Dardeno TA,Chou SH,Moon HS,et al.Leptin in human physiology and therapeutics[J].Front Neuroendocrinol,2010,31(3):377-393.
  • 5Housa D,Housova J,Vernerova Z,et al.Adipocytokines and cancer[J].Physiol Res,2006,55(3):233-244.
  • 6Weryńska B,Kosacka M,Goecki M,et al.Leptin serum levels in cachectic and non-cachectic lung cancer patients[J].Pneumonol Alergol Pol,2009,77(6):500-506.
  • 7Terzidis A,Sergentanis TN,Antonopoulos G,et al.Elevated serum leptin levels:a risk factor for non-small-cell lung cancer?[J].Oncology,2009,76(1):19-25.
  • 8Carpagnano GE,Spanevello A,Curci C,et al.IL-2,TNF-alpha,and leptin:local versus systemic concentrations in NSCLC patients[J].Oncol Res,2007,16(8):375-381.
  • 9Petridou ET,Sergentanis TN,Antonopoulos CN,et al.Insulin resistance:an independent risk factor for lung cancer?[J].Metabolism,2011.[Epub ahead of print].
  • 10Fenton JI,Hursting SD,Perkins SN,et al.Leptin induces an Apc genotype-associated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation[J].Carcinogenesis,2007,28(2):455-464.

共引文献19

同被引文献4

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部